Mifegymiso information update in Canada: Ultrasound no longer mandatory
In plain language
This is an information update regarding Mifegymiso sold in Canada. Health Canada has updated the prescribing information for Mifegymiso. An ultrasound is no longer mandatory before the drug is prescribed.
What to do
- Consult your healthcare provider for more information.
- Refer to the updated product monograph for details.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
This is an information update regarding Mifegymiso sold in Canada. Health Canada has updated the prescribing information for Mifegymiso. An ultrasound is no longer mandatory before the drug is prescribed.
What should consumers do?
Consult your healthcare provider for more information. Refer to the updated product monograph for details.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on April 16, 2019.
Is the Mifegymiso brand affected by this recall?
Yes, Mifegymiso products are affected by this recall. This is an information update regarding Mifegymiso sold in Canada. Health Canada has updated the prescribing information for Mifegymiso. An ultrasound is no longer mandatory before the drug is prescribed.